These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25560582)

  • 21. Single-nucleotide polymorphism in CYP1A1, CYP1B1, CYP2B6, CYP2C8, and CYP2C9 genes and their association with gastrointestinal cancer: A hospital-based case-control study.
    Patil MN; Datkhile KD; Gudur AK; Gudur RA; Patil SR
    J Cancer Res Ther; 2024 Jan; 20(1):216-223. PubMed ID: 38554324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population.
    Polonikov A; Kharchenko A; Bykanova M; Sirotina S; Ponomarenko I; Bocharova A; Vagaytseva K; Stepanov V; Bushueva O; Churnosov M; Solodilova M
    Gene; 2017 Sep; 627():451-459. PubMed ID: 28687336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.
    Smith HE; Jones JP; Kalhorn TF; Farin FM; Stapleton PL; Davis CL; Perkins JD; Blough DK; Hebert MF; Thummel KE; Totah RA
    Pharmacogenet Genomics; 2008 Nov; 18(11):943-53. PubMed ID: 18769365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of functional CYP2C8,CYP2C9,CYP3A5,and ABCB1 genetic variants on the pharmacokinetics of insulin sensitizer pioglitazone in Chinese Han individuals.
    Yin SJ; Qi HM; Wang X; Zhang P; Lu Y; Wei MJ; Li P; Qi GZ; Lou YQ; Lu C; Zhang GL
    Pharmacogenet Genomics; 2017 Apr; 27(4):125-134. PubMed ID: 28099407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
    Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variants in epoxyeicosatrienoic acid processing and degradation pathways are associated with gestational diabetes mellitus.
    Lai S; Yan D; Xu J; Yu X; Guo J; Fang X; Tang M; Zhang R; Zhang H; Jia W; Luo M; Hu C
    Nutr J; 2023 Jun; 22(1):31. PubMed ID: 37370090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrosequencing method for genotyping cytochrome P450 CYP2C8 and CYP2C9 enzymes.
    Hruska MW; Frye RF; Langaee TY
    Clin Chem; 2004 Dec; 50(12):2392-5. PubMed ID: 15563491
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
    Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
    Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.
    Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K
    Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population.
    Polonikov A; Bykanova M; Ponomarenko I; Sirotina S; Bocharova A; Vagaytseva K; Stepanov V; Churnosov M; Bushueva O; Solodilova M; Shvetsov Y; Ivanov V
    Clin Exp Hypertens; 2017; 39(4):306-311. PubMed ID: 28513222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile.
    Börgel J; Bulut D; Hanefeld C; Neubauer H; Mügge A; Epplen JT; Holland-Letz T; Spiecker M
    BMC Cardiovasc Disord; 2008 Dec; 8():41. PubMed ID: 19105833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haplotype analysis of the CYP2J2 gene associated with myocardial infarction in a Chinese Han population.
    Jie Z; Hong K; Jianhong T; Biao C; Yongmei Z; Jingchuan L
    Cell Biochem Funct; 2010 Aug; 28(6):435-9. PubMed ID: 20597138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium.
    Jia J; Davis CM; Zhang W; Edin ML; Jouihan S; Jia T; Bradbury JA; Graves JP; DeGraff LM; Lee CR; Ronnekleiv O; Wang R; Xu Y; Zeldin DC; Alkayed NJ
    Exp Neurol; 2016 May; 279():75-85. PubMed ID: 26902473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids.
    Kirchheiner J; Meineke I; Fuhr U; Rodríguez-Antona C; Lebedeva E; Brockmöller J
    Pharmacogenomics; 2008 Mar; 9(3):277-88. PubMed ID: 18303964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.
    Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC
    FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.
    Dorado P; Cavaco I; Cáceres MC; Piedade R; Ribeiro V; Llerena A
    Eur J Clin Pharmacol; 2008 Oct; 64(10):967-70. PubMed ID: 18548238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
    Jose R; Chandrasekaran A; Sam SS; Gerard N; Chanolean S; Abraham BK; Satyanarayanamoorthy K; Peter A; Rajagopal K
    Fundam Clin Pharmacol; 2005 Feb; 19(1):101-5. PubMed ID: 15660966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.
    López-Rodríguez R; Novalbos J; Gallego-Sandín S; Román-Martínez M; Torrado J; Gisbert JP; Abad-Santos F
    Pharmacol Res; 2008 Jul; 58(1):77-84. PubMed ID: 18694831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.
    Genvigir FDV; Nishikawa AM; Felipe CR; Tedesco-Silva H; Oliveira N; Salazar ABC; Medina-Pestana JO; Doi SQ; Hirata MH; Hirata RDC
    Pharmacotherapy; 2017 May; 37(5):535-545. PubMed ID: 28316087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage.
    Donnelly MK; Conley YP; Crago EA; Ren D; Sherwood PR; Balzer JR; Poloyac SM
    J Cereb Blood Flow Metab; 2015 Feb; 35(2):267-76. PubMed ID: 25388680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.